Grant: Engage Grants Program
University of Toronto
$25,000.00
Phage display validation of custom biosurface coated microplates
EF 2011-12
Résumé
Antibodies are a natural defense mechanism of animals to foreign proteins entering a body. They are specific to
each protein and can be used in medicine to disable proteins of interest in order to treat a variety of diseases
including cancer. Traditionally, antibodies to a specific protein have been isolated by injecting animals with the
protein of interest and allowing the animal's natural immune system to create antibodies that are recovered by
researchers. This can prove cumbersome with little guarantee of recovering a functional antibody; indeed,
numerous proteins fail to illicit a functional antibody after months of work for a variety of reasons. In order to
circumvent these difficulties we have employed a technology called phage display that uses bacteria to make
synthetic antibodies. Once isolated, we can further strengthen the binding and/or specificity of the antibodies to
the selected target (protein), a technique not possible with traditional antibody discovery methods. Phage
display, in its fastest and most facile form, requires immobilization of the protein onto a plastic surface before
incubation of the protein with a library of antibodies. In order for the isolated antibody to recognize the protein
within the body, however, the protein must fold on the plastic surface in the same way as it would fold in the
body, a feature that can be difficult for many classes of proteins. Modifying the plastic surface to promote
proper folding and better attachment has been the goal of many groups including Dalenyi Biosurfaces Inc. who
have developed novel coatings to address this exact issue. These coatings will be validated in the Sidhu lab
using well established techniques and proteins (with antibodies isolated previously). Furthermore, coatings for
specific classes of proteins well known to be prone to misfolding will be developed and validated thereby
expediting antibody discovery.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
412764-2011
Name nom
Sidhu, Sachdev
Department département
Banting and Best Dept of Medical Research
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5401
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Immunochemistry
Research subject fr
Chimie immunologique
Partie
1
Nb partie
1
Application title
Phage display validation of custom biosurface coated microplates
Keyword
NSERC
Application summary
Antibodies are a natural defense mechanism of animals to foreign proteins entering a body. They are specific to
each protein and can be used in medicine to disable proteins of interest in order to treat a variety of diseases
including cancer. Traditionally, antibodies to a specific protein have been isolated by injecting animals with the
protein of interest and allowing the animal's natural immune system to create antibodies that are recovered by
researchers. This can prove cumbersome with little guarantee of recovering a functional antibody; indeed,
numerous proteins fail to illicit a functional antibody after months of work for a variety of reasons. In order to
circumvent these difficulties we have employed a technology called phage display that uses bacteria to make
synthetic antibodies. Once isolated, we can further strengthen the binding and/or specificity of the antibodies to
the selected target (protein), a technique not possible with traditional antibody discovery methods. Phage
display, in its fastest and most facile form, requires immobilization of the protein onto a plastic surface before
incubation of the protein with a library of antibodies. In order for the isolated antibody to recognize the protein
within the body, however, the protein must fold on the plastic surface in the same way as it would fold in the
body, a feature that can be difficult for many classes of proteins. Modifying the plastic surface to promote
proper folding and better attachment has been the goal of many groups including Dalenyi Biosurfaces Inc. who
have developed novel coatings to address this exact issue. These coatings will be validated in the Sidhu lab
using well established techniques and proteins (with antibodies isolated previously). Furthermore, coatings for
specific classes of proteins well known to be prone to misfolding will be developed and validated thereby
expediting antibody discovery.